Biocon eyes market share expansion in developed, emerging markets: Kiran Mazumdar-Shaw

“Trastuzumab (monoclonal antibody used to treat breast and stomach cancers) is another big opportunity we are looking at, not just in the US and Europe, but it is a very large global opportunity with growth potential for us,” Mazumdar-Shaw said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news